Datametrex AI Sees Medi-Call Launch In-Person Care Beta
Following the launch of its Medi-Call mobile app just days ago, Datametrex AI (TSXV: DM) this morning had another announcement for its new subsidiary. The company has indicated that it has launched a “beta” in-person patient care program.
The program will see the company launch expanded services through the subsidiary that includes in-person visits at residential or work settings for clients – meaning the traditional model of care has been flipped around, with physicians now going directly to their patients. The beta program has initially launched within the Greater Vancouver Area.
Appointments for the program are to be made via the Medi-Call app, allowing consumers to “go on with their daily business until the physician arrives.” Much like other delivery services, consumers can track the progress and location of their doctor for better insight on when they will be ready to serve.
Dr Omar Sharif, President of Medi-Call commented on the new service, saying, “We are excited to announce the addition of a crucial service for Medi-Call subscribers. A physical visit by a physician has been proven optimal for efficacious diagnostic and treatment results, as not all primary care level visits can be dealt with safely and efficiently via video or telehealth. In-person Medi-Call visits in addition to e-health improve the patients’ experience by increasing access to care and healthcare delivery at large.”
Datametrex AI last traded at $0.18 on the TSX Venture.
FULL DISCLOSURE: DataMetrex AI Limited is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover DataMetrex AI Limited on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
As the founder of The Deep Dive, Jay is focused on all aspects of the firm. This includes operations, as well as acting as the primary writer for The Deep Dive’s stock analysis. In addition to The Deep Dive, Jay performs freelance writing for a number of firms and has been published on Stockhouse.com and CannaInvestor Magazine among others.
